Cardiovascular Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/cardiovascular/ The leading site for news and procurement in the pharmaceutical industry Mon, 25 Mar 2024 16:24:44 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.2 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png Cardiovascular Archives - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/cardiovascular/ 32 32 Novo shells out $1.1bn to buy Cardior to expand cardiovascular pipeline https://www.pharmaceutical-technology.com/news/novo-1-1bn-buy-cardior-expand-cardiovascular-pipeline/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/shutterstock_2355810739-3.jpg Mon, 25 Mar 2024 16:24:17 +0000 https://www.pharmaceutical-technology.com/news/novo-1-1bn-buy-cardior-expand-cardiovascular-pipeline/ FDA approves Wegovy for reducing risk of cardiovascular death https://www.pharmaceutical-technology.com/analyst-comment/fda-approves-wegovy-for-reducing-risk-of-cardiovascular-death/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/shutterstock_2338223569.jpg Wed, 20 Mar 2024 17:09:03 +0000 https://www.pharmaceutical-technology.com/analyst-comment/fda-approves-wegovy-for-reducing-risk-of-cardiovascular-death/ FDA approves Idorsia’s once-daily antihypertensive Tryvio https://www.pharmaceutical-technology.com/news/fda-approves-idorsias-once-daily-antihypertensive-tryvio/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/shutterstock_2390697953-1-min-scaled.jpg Wed, 20 Mar 2024 16:46:07 +0000 https://www.pharmaceutical-technology.com/news/fda-approves-idorsias-once-daily-antihypertensive-tryvio/ Novo expands Wegovy’s US label to reduce cardiovascular events https://www.pharmaceutical-technology.com/news/novo-expands-wegovys-us-label-to-reduce-cardiovascular-events/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/shutterstock_2355810739-2.jpg Mon, 11 Mar 2024 15:05:44 +0000 https://www.pharmaceutical-technology.com/news/novo-expands-wegovys-us-label-to-reduce-cardiovascular-events/ Novo Nordisk signs $1.46bn deal to develop molecular glue therapies https://www.pharmaceutical-technology.com/news/novo-nordisk-signs-1-46bn-deal-to-develop-molecular-glue-therapies/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/shutterstock_2007847310.jpg Tue, 27 Feb 2024 15:16:07 +0000 https://www.pharmaceutical-technology.com/news/novo-nordisk-signs-1-46bn-deal-to-develop-molecular-glue-therapies/ United Therapeutics sues FDA over handling of Liquidia’s NDA https://www.pharmaceutical-technology.com/news/united-therapeutics-sues-fda-over-handling-of-liquidias-nda/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/shutterstock_2009268623.jpg Thu, 22 Feb 2024 15:31:47 +0000 https://www.pharmaceutical-technology.com/news/united-therapeutics-sues-fda-over-handling-of-liquidias-nda/ CSL’s ‘big’ post-heart attack drug fails in Phase III trial https://www.pharmaceutical-technology.com/news/csls-big-post-heart-attack-drug-fails-in-phase-iii-trial/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/shutterstock_2085383608.jpg Mon, 12 Feb 2024 12:01:41 +0000 https://www.pharmaceutical-technology.com/uncategorized/csls-big-post-heart-attack-drug-fails-in-phase-iii-trial/ Silence announces $120m private placement for depositary shares https://www.pharmaceutical-technology.com/news/silence-therapeutics-private-placement/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/Silence-.jpg Tue, 06 Feb 2024 08:38:42 +0000 https://www.pharmaceutical-technology.com/news/silence-therapeutics-private-placement/ BridgeBio secures $1.25bn for genetic therapy development https://www.pharmaceutical-technology.com/news/bridgebio-secures-funds/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/BridgeBio-.jpg Fri, 19 Jan 2024 08:14:34 +0000 https://www.pharmaceutical-technology.com/news/bridgebio-secures-funds/ Comanche raises $75m to develop preeclampsia therapy https://www.pharmaceutical-technology.com/news/comanche-raises-75m-to-develop-preeclampsia-therapy/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/shutterstock_632642750.jpg Thu, 18 Jan 2024 11:14:56 +0000 https://www.pharmaceutical-technology.com/news/comanche-raises-75m-to-develop-preeclampsia-therapy/